摘要:为考查氢溴酸常山酮预混剂在靶动物鸡上应用的安全性,本试验以推荐剂量的1、3、5倍剂量给药,饲喂42天,通过对鸡的增重情况、血液学与血液化学指标及组织病理学检查,了解受试药物在鸡中的剂量-反应曲线,即从有效剂量到毒性作用;了解鸡对药物中毒剂量的临床反应特征;了解受试药物有效剂量、推荐剂量和中毒剂量对靶动物的组织病理学和生理生化指标影响的变化特征,从而评价氢溴酸常山酮对鸡的安全性。试验结果表明,各试验组与对照组的血液化学指标和血液学指标个别有显著差异,但总体在参考范围内,尸体解剖未见各组织器官有明显的异常变化,组织学检查也未见有明显病理变化,但当饲料中的药物浓度超过一定浓度时会影响鸡只采食和鸡日增重,甚至会使鸡只行为异常,因此在临床应用时应主要混合均匀度问题。29824 毕业论文关键词:氢溴酸常山酮;安全性;鸡;靶动物。
Evaluation of the safety of Halofuginone Hydrobromide premixes on chickens
Abstract:To evaluate the safety of halofuginone hydrobromide pre-blends in target animal chickens,the experiment was administered at a recommended dose of 1,3,5 times for 42 days.Through the weight gain of the chicken,hematology and hematology and histopathological examination to understand the dose-response curve of the test drug in chickens, from effective dose to toxic effects; to understand the clinical response characteristics of the drug dose of chicken; to understand the effective dose of the test drug , Recommended dose and poisoning dose on the target animal pathology and physiological and biochemical indicators of the changes in characteristics, to evaluate the halofuginone hydrobromide on chicken safety. The results showed that there were no significant differences in hematological and hematological indexes between the experimental group and the control group. There were no obvious abnormal changes in the organs and organs of the autopsy. There was no pathological changes in histological examination, However, when the concentration of drug in the feed exceeds a certain concentration, it will affect the daily feeding of chickens and the daily gain of chickens, even can make chickens behave differently.Therefore, it is necessary to mix the homogeneity evenly in clinical application.
Key words: Halofuginone hydrobromide ;Safety;Chicken;Target animal.
目 录